All event times are Pacific Time Zone.
7:00 am - 12:00 nn
7:30 am - 8:30 am
Health Policy Update
Donna Bednarski, MSN, RN, ANP-BC, CNN, CNP
James Twaddell, ANNA Health Policy Consultant
Health policy experts will review key legislative, regulatory, and health policy issues affecting nephrology nursing, including value-based models. Policies that have the potential to influence nursing practice, education, and the delivery of care to patients with kidney disease will be discussed.
8:45 am - 10:00 am
Concurrent Sessions (311-313)
Indumathy Varadarajan, MBBS
This session will focus on patients with kidney disease who also have various blood dyscrasias. Causes and symptoms of blood dyscrasias as well as medical and nursing interventions for treatment plans will be highlighted. Pharmacologic therapies also will be reviewed.
Evaluation of Patient Frailty and Implications for Care
Debra Hain, PhD, APRN, AGPCNP-BC, FAAN, FAANP, FNKF
What is patient frailty, and how does it impact care? This session will begin with a review of the criteria to determine frailty and how to evaluate patients for frailty. The significance of the results of the evaluation, recommendations for care, and strategies to improve outcomes for frail patients also will be discussed.
Optimizing Kidney Care Education Using Digital Technology
Todd Maddox, PhD
Low health literacy can be a major barrier to successful health outcomes, especially in individuals with kidney disease. Digital technologies offer an opportunity to address this barrier. This session will explore options for incorporating technology to improve patient care and education, including case studies using computer-based learning, virtual reality learning, and augmented reality learning.
10:15 am - 11:30 am
Closing General Session
KDIGO Guidelines: Blood Pressure Management in Chronic Kidney Disease
Chantale Daifi, PharmD
KDIGO continues to refine guidelines for managing hypertension. Dr. Daifi will highlight the updates in the most recent edition of the Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021) and discuss how these new recommendations may impact patient assessment and care.